Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL123299 | 0.79 | POLB (0.30) | POLB | |
| SCHEMBL1578764 | 0.78 | LMNA (0.32) | LMNA | |
| SCHEMBL5855092 | 0.77 | POLB (0.35) | LMNAPOLB | |
| SCHEMBL417571 | 0.76 | PLA2G7 (0.39) | LMNAPOLB | |
| SCHEMBL22578 | 0.75 | — | — | |
| Hypochlorous Acid SCHEMBL6047066 | 0.75 | — | — | |
| SCHEMBL10874274 | 0.74 | — | — | |
| SCHEMBL6047067 | 0.73 | — | — | |
| SCHEMBL1320959 | 0.73 | POLB (0.45) | POLB | |
| SCHEMBL7764140 | 0.72 | LMNA (0.34) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4212937-A | NITROGEN-CONTAINING HETEROCYCLIC BASE | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-07-15 | — | — | US | claimed |
| US-11673889-B2 | Substituted imidazo[4,5-c][1,8]naphthyridines as phosphodiesterase inhibitors | NANJING ZHENGXIANG PHARMACEUTICALS CO., LTD. (CN) | 2023-06-13 | — | — | US | disclosed |
| WO-2022161416-A1 | AROMATIC COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 武汉朗来科技发展有限公司 | 2022-08-04 | — | — | WO | disclosed |
| US-20170273307-A1 | SILANE-BASED ANTIMICROBIAL COATINGS AND METHODS OF MAKING AND USING THE SAME | UNIV TRENT (CA) | 2017-09-28 | — | — | US | disclosed |
| EP-0759189-B1 | PHOTOTHERMOGRAPHIC ELEMENT WITH PRE-FORMED IRIDIUM-DOPED SILVER HALIDE GRAINS | EASTMAN KODAK CO (US) | 2001-05-30 | — | — | EP | disclosed |
| EP-0746799-B1 | PHOTOTHERMOGRAPHIC ELEMENT WITH CORE-SHELL-TYPE SILVER HALIDE GRAINS | IMATION CORP A DELAWARE CORP (US) | 1998-07-15 | — | — | EP | disclosed |
| EP-0759189-A1 | PHOTOTHERMOGRAPHIC ELEMENT WITH PRE-FORMED IRIDIUM-DOPED SILVER HALIDE GRAINS | Imation Corp. (US) | 1997-02-26 | — | — | EP | disclosed |
| EP-0746799-A1 | PHOTOTHERMOGRAPHIC ELEMENT WITH CORE-SHELL-TYPE SILVER HALIDE GRAINS | Imation Corp (a Delaware Corporation) (US) | 1996-12-11 | — | — | EP | disclosed |
| US-5563030-A | HIGH DENSITY, RESOLUTION, SHARPNESS, SHELF LIFE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-10-08 | — | — | US | disclosed |
| WO-1995030931-A1 | PHOTOTHERMOGRAPHIC ELEMENT WITH PRE-FORMED IRIDIUM-DOPED SILVER HALIDE GRAINS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-11-16 | — | — | WO | disclosed |
| WO-1995022785-A1 | PHOTOTHERMOGRAPHIC ELEMENT WITH CORE-SHELL-TYPE SILVER HALIDE GRAINS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-08-24 | — | — | WO | disclosed |
| US-5434043-A | Photothermographic element with pre-formed iridium-doped silver halide grains | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-07-18 | — | — | US | disclosed |
| US-5382504-A | Negative photographic element | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-01-17 | — | — | US | disclosed |
| US-4347310-A | INCREASED PHOTOSENZITIVITY USING GUANIDINE DERIVTIVES AS SENSITIZERS; PHOTOSTABILITY; STORAGE STABILITY | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1982-08-31 | — | — | US | disclosed |
| US-4212937-A | NITROGEN-CONTAINING HETEROCYCLIC BASE | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170273307-A1 | SILANE-BASED ANTIMICROBIAL COATINGS AND METHODS OF MAKING AND USING THE SAME | CUTA, SMURF1, TET1 | LMNA 2746/4885POLB 3134/4885 |
| US-11673889-B2 | Substituted imidazo[4,5-c][1,8]naphthyridines as phosphodiesterase inhibitors | ENPP1, ENPP3, PDE4A | LMNA 1314/4885POLB 1524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.